C57BL/6 (1-1-2 b) mice were primed with the bovine RF strain of rotavirus to study the induction of CD8 + cytotoxic T lymphocytes (CTLs). These rotavirusspecific CTLs were detected only after in vitro restimulation with the virus. Using a recombinant vaccinia virus we identified the RF VP7 protein as a major target of these CTLs. The response against this protein was obtained also after in vitro restimulation with simian SA11 and human WA strains of rotavirus. Using published D b and K b allele-specific motifs to predict possible CTL epitopes in the RF VP7 protein, we synthesized and tested 18 predicted peptides of VP7. Only one peptide was able to sensitize target cells at a concentration below 5 × 10 -7 M. This CTL epitope was also induced by immunization with the RF VP7 expressed with a baculovirus vector, and was shown to be immunodominant by its capacity to inhibit, in an unlabelled target assay, the bulk response against ceils infected with recombinant vaccinia virus expressing VP7. This CTL epitope overlaps the H2 signal peptide of the protein.
Introduction
Rotaviruses have been recognized as the most important cause of severe gastroenteritis in infants. Because of the worldwide public health problem caused by this disease, the production of a vaccine against rotaviruses is an important priority of the WHO (World Health Organization, 1989) . Protection against rotaviruses has initially been correlated with the presence of serotype-specific neutralizing antibodies against the virus (Matsui et al., 1989) , but recently support for a possible role of CD8 + cytotoxic T lymphocytes (CTLs) has also been obtained (Off:it & Dudzik, 1990; Dharakul et al., 1990) . CTLs appear to recognize conserved (i.e. cross-reactive) determinants of the virus that it would be important to include in a vaccine formulation (Offit & Dudzik, 1988) . Therefore a basic understanding of factors determining the induction of CTLs against a given virus protein is important. In influenza virus the internal conserved nucleoprotein is an important target of CTLs in mice and humans (Townsend et al., 1984; Gotch et al., 1987) . These and other results suggest that CTLs are induced preferentially by internal, conserved non-glycosylated proteins of a virus (Bangham et al., 1986; Puddington et al., 1986) .
At present, we do not know the rules for predicting, for a given virus, which of its proteins will be a major target of CTLs (Whitton et al., 1988; Openshaw et al., 1990) . Although the prevalence of CTLs to a given virus protein varies with the major histocompatibility complex (MHC) of the individual, some proteins appear to be recognized by CTLs more frequently than others (Bennink & Yewdell, 1990 ). VP7, a rotavirus glycoprotein, has been shown to be an important target for cross-reactive rotavirus-specific CTLs in C57BL/6 mice (Offit et al., 1991) . We decided to study the CTL response induced by the RF strain of rotavirus. Using a vaccinia virus recombinant expressing the RF VP7, we confirmed that this protein is a major target of cross-reactive CTLs in C57BL/6 mice, and we sought to identify the epitopes recognized by these CTLs.
Identification of the CTL epitopes of a protein has been done principally by synthesizing overlapping peptides of the whole protein (Kumar et al., 1988) , by using vaccinia virus recombinants expressing parts of the protein (Whitton et al., 1988) or by using algorithms to predict the possible epitopes (Takahashi et at., 1988) . The first approaches are rather costly and the last has met with variable results (Schulz et al., 1989; Shirai et al., 1992b) . Allele-specific motifs for peptides that are presented by individual class I MHC molecules have recently been reported (Falk et al., 1991) . The practical importance of these motifs for predicting T cell epitopes has been shown in several papers (Pamer et al., 1991; Deckhut et al., 1992) . In the present work we have used these motifs to determine a CTL epitope on VP7. This epitope overlaps the signal peptide of the protein. As signal peptides might be processed in a particular manner for their presentation with class I molecules (see Discussion), this association may be relevant to the dominant nature of the epitope.
Methods
Animals. C57BL/6 (H-2 ~) female mice, 8 to 10 weeks old, were obtained from Charles River Laboratories, and housed (for no more than 7 days) in air-filtered isolators. Mice, bred in the same room as those used, were tested monthly by the supplier for antibodies against rotavirus EDIM by an ELISA and always found negative. Preimmune serum and serum from mice not inoculated with RF, but kept for the same time in the same housing facilities, were also tested by ELISA against caesium chloride-purified RF rotavirus as previously described (Borrfis-Cuesta et al., 1987) and found negative. Mice immunized with RF were positive in this test.
Cells. MA104 cells were grown as previously described (L'Haridon & Scherrer, 1976 (Takahashi et al., 1988 ) (a gift from A. Hosmalin, H6pital de la Salp6triere, Paris, France) were grown in DMEM (Gibco-BRL) containing 10 % heat-inactivated FCS, 100 ~tg/ ml streptomycin sulphate and 100 units/ml penicillin. P815 (H-2 a) cells transfected with the K b and D b molecules (obtained from P. Romero, Ludwig Institute for Cancer Research, Epalinges, Switzerland) were grown in the same medium but supplemented with G418 (Gibco-BRL) at 1 mg/ml to ensure the expression of the transfected molecule. The presence of the transfected gene products on these cells was analysed in a FACScan flow cytometer (Becton Dickinson) using the K10 65 1 (anti-K b) and 28 14 8 (anti-D b) (Allen et aL, 1984) Viruses. Three times plaque-purified stocks of the RF strain of bovine rotavirus (serotype G6), of simian rotavirus SAI 1 (serotype G3) and the WA strain of human rotavirus (serotype GI) (a gift of H. Greenberg, Stanford University, Ca., U.S.A.) were grown in MA104 cells in the presence of trypsin (0-44 gg/ml; Sigma type IX) as previously described (L'Haridon & Scherrer, 1976) .
Construction of VP7 recombinants.
A vaccinia virus recombinant with gene 9 of RF rotavirus (Charpilienne et al., I986) (referred to as VV7) was produced as previously described (Poncet et al., I990) .
Briefly, the gene coding for VP7 was introduced into plasmid pGS20 (a gift of B. Moss, Laboratory of Viral Diseases, National Institutes of Allergy and Infectious Diseases, Bethesda, Md., U.S.A.) and the product was used to transfect cells infected with the IHD strain of vaccinia virus (a gift of D. Beaud, Institut J. Monod, Paris, France). Recombinants were selected by growth in cllD cells, in the presence of 25 gg/ml bromodeoxyuridine, and identified by dot blot hybridization. After two plaque purification steps, the selected clone was confirmed as being the correct recombinant by immunoprecipitation of VP7 with an anti-rotavirus specific antiserum. Viral stocks were produced and titrated on MA104 cells as described previously (Poncet et al., 1990) .
The thymidine kinase-negative vaccinia virus (referred to as VVD4) used as a negative control was obtained using the same protocol.
For producing the recombinant baculovirus (referred to as BacRF9), a full-length eDNA clone of RF gene 9 was amplified by PCR using two oligonucleotides corresponding to its 5' and 3' ends. Amplified products were subcloned into the Klenow polymerase filled-in BamHI site of transfer vector pVL941. The recombinant baculovirus was obtained by cotransfection of Spodoptera frugiperda cells (sfg) with recombinant pVL941 and wild-type baculovirus DNA (Summers & Smith, 1987) . The protein was produced in Sf9 cells as described (Summers & Smith, 1987) . The polyhedrin-negative virus AcRP6-SC (Kitts et al., 1990) Cytotoxicity assay. For preparation of effector cells, mice were sacrificed by vertebral dislocation 6 days after immunization, and spleen single cell suspensions were prepared with complete medium (CM) (i.e. RPMI-1640 containing 10 % heat-inactivated FCS, 100 ~tg/ ml streptomycin sulphate, 100 units/ml penicillin, 2 mM-L-glutamine, 2-5 mM-sodium pyruvate, 20 mM-HEPES and 30 gM-2-mercaptoethanol) and mixed in a 2: 1 ratio with stimulator cells. These cells, obtained from spleens of non-immune animals, had been incubated previously (30 rain at 37 °C) with different rotaviruses at an m.o.i, of 1 and then irradiated at 2000 rad. The cell mixture was adjusted to 5 x 106 cells/ml, distributed to 24-well plates and cultured with 5 % CO 2 at 37 °C for 5 days. The same protocol was used for the in vitro stimulation with the peptide but the stimulator cells (2.5 x 106 cells/ml) were incubated in CM with 10, 1 and 0"1 mM of peptide 3 (P3) for 2 to 4 h at 37 °C before irradiation.
Target cells (MC57, L929 and 18Neo cells) were trypsinized, washed, counted and infected in suspension (DMEM with 20 mM-HEPES without FCS) at an m.o.i, of 75 to 150 for RF virus (the titre of the stock used was 1.5 x l0 s p.f.u./ml) or of 2 to 5 for the vaccinia viruses. After 2 h at 37 °C, the cells (1 x 106 to 3 x 106) were centrifuged, labelled with 100 gCi of 51Cr (Amersham) for 1 h at 37 °C, washed three times and distributed in 96-well plates (5000 to 10 000 cells/well). Effector cells were added at the appropriate concentration to obtain the desired effector: target (E: T) cell ratios and to complete a total volume of 200 ~1. After 5 h of incubation at 37 °C, 50 lal samples were taken from each well and counted in a gamma counter. For calculation of spontaneous and maximum release of 51Cr, target cells were incubated with medium only and 10% Triton X-100 respectively. Spontaneous release was generally below 20 %. The percentage of specific alCr release was calculated with the formula [(experimental releasespontaneous release)/(maximmn release-spontaneous release)] x 100.
For producing target cells with peptides, MC57 cells were trypsinized, labelled with 51Cr as described above, and incubated (10000 cells/well in 96-well plates) for 2 h with different dilutions of peptide before addition of effector cells. For experiments in which P815 cells were used as targets with the peptide, the cells were washed, incubated with peptides at 10 -~ M for 1 h at 37 °C and then labelled with 51Cr and treated as in the standard protocol. Peptides were not toxic to MC57 cells since the spontaneous 51Cr release of cells incubated with each one of the peptides was similar to the spontaneous release with medium only. All experiments were done in triplicate except for those of Fig.  2(b, c) and Fig. 3 which were done in duplicate. The S.E.M. of replicate cultures was less than 10 % of the mean. All experiments were repeated at least three times except those of Fig. 5 (b) which were done twice. A response was considered positive if it was above 10 % specific lysis and at least double the response against control target cells.
Complement depletion. Anti-Thy-1.2 MAb (clone 5a-8) and 'LowTox' rabbit complement were purchased from Cedarlane Laboratories, and used according to the manufacturer's instructions (at a dilution of 1:20). Anti-CD4 (L3T4) MAb (clone YTS 919.1, purchased from Sera-Lab) and rat ascites fluid of the anti-CD8 (Lyt.2.2) clone H35.17.2 (Golstein et al., 1982) , a gift of Dr Bernard Charley, INRA, Jouy-en-Josas, France, were used under the same conditions, after appropriate dilutions had been determined in preliminary experiments. Depletion was monitored by counting cells in the presence of trypan blue, and by immunofluorescence (using the respective MAbs), before and after the depletion.
Peptide synthesis. Peptides were synthesized by the solid-phase method of Merrifield (1963) using the Fmoc alternative (Atherton et al., 1981) with a manual multiple solid-phase synthesizer which can synthesize up to 96 independent peptides (Borrfis- Cuesta, 1990 ). The ninhydrin test of Kaiser et al. (1970) was used to monitor coupling and deprotection steps. At the end of the synthesis, peptides were cleaved, deprotected, washed twice with diethyl ether and lyophilized in 10 mMammonium bicarbonate. They were used without further purification. Stock solutions (1 raM) of peptides 1, 4, 5, 7, 9, 11, 12 and 15 were prepared in RPMI medium with 20 mM-HEPES. For the other peptides various amounts of DMSO were used as a diluent.
Results

VP7 is a major target of cross-reactive CD8 + CTLs in C57BL/6 mice
Preliminary experiments showed that at the dose tested (107 p.f.u, of RF/mouse) no primary CTL response against RF was detectable (data not shown). However after a 5 day in vitro restimulation with the RF virus, an MHC-restricted CTL response was detected (Fig. 1) . The levels of cytotoxicity against cells infected with VV7 were of similar intensity as levels against those infected with RF virus indicating that VP7 must be an important CTL target. These CTLs were not induced by in vitro (see Table 1 ) or in vivo stimulation with the supernatant of mock-infected MA104 cells (data not shown). The CTL response against VP7 was MHC class I-restricted as the targets do not express MHC class II molecules and the 18Neo (H-2 a) and L929 (H-2 k) cells infected with VV7 were not lysed (Fig. 1) 
matched BALB/c (H-U) and C3H (H-2 ~) vaccinia virusspecific effector cells, respectively (results not shown).
Depleting the effector cell population of T cells by treatment with anti-Thy. 1.2 and of CD8 + cells with anti-CD8 MAbs and complement completely suppressed the response against VV7-infected targets (4.9 and 2"6% specific lysis at an E:T ratio of 20: 1). In contrast, the same treatment with the anti-CD4 MAb had little effect (26.6 % specific lysis at the same E:T ratio), establishing the phenotype of the effector cells as CD8 + CD4-T cells.
Cross-reactivity of the CTL response with the WA and SAIl rotavirus strains
To confirm we were working with cross-reactive CTLs similar to those reported previously (Offit et al., 1991) , we used the WA and SAll rotavirus strains as antigens for in vitro stimulation of RF-primed CTLs. CTLs restimulated with both rotavirus strains recognize VV7-and RF-infected target cells specifically (Fig. 2) . Similar results were obtained when the in vivo immunization with RF was done orally (results not shown).
Synthesis of peptides and their recognition by CTLs
In an attempt to identify the cross-reactive CTL epitope we generated a number of peptides based on the MHC class I allele-specific motifs proposed by Falk et al. (1991) . These motifs predict the peptide length and the amino acids at certain positions called anchor positions. The D b allele motif predicts peptides that have nine amino acids, an asparagine in position 5 and methionine, isoleucine or leucine in position 9. For the K b allele the prediction is of peptides that are 8 amino acids long and have a tyrosine or phenylalanine in position 5 and isoleucine, valine, methionine or leucine in position 8. Peptide sequences in RF VP7 that conformed to these rules were identified and synthesized (Fig. 3a) . Additionally peptides 2, 5, 10 and 17, from relatively conserved sequences ofVP7 (Nishikawa et al., 1989) , and containing only a single anchor residue, were synthesized and tested. Since for K b (Falk et al., 1991 ) the peptide length of epitopes known to be restricted by this molecule, the K b peptides were made 10 amino acids long, and peptide 4, which would be considered as having the second anchor position in position 10 instead of 9, was included also. Fig. 3 (b) shows that the CTLs from RF-immunized mice recognized peptides P3, P6, P7, P10, Pll and P16. The response against the various peptides was dependent on the in vivo immunization with RF as mock-infected mice and mice infected with VVD4 were unable to prime this response.
It has been shown previously (Dharakul et al., 1991 ) that immunization with baculovirus-expressed recom- P3 10 gM 5-4 9"9 4-2 12-6 4"0 12-3 P3 1 p.M 0"8 13"2 2"2 36"4 1'3 30"8 P3 0"1 laM 2"6 25'3 2"7 51'7 2"9 44'9 Mock 13"5 11'3 12'6 8"6 4.9 4'5 * RF-primed CTLs were restimulated with each peptide at the indicated concentration or with no peptide.
t Percentage specific lysis is shown against target cells infected with indicated viruses, or treated with P8, P3 or the supernatant of mockinfected MA104 cells. Shown are the results using an E:T ratio of 30; E:T ratios of 10 and 5 showed a clear effector dose effect. Values corresponding to at least 10 % of lysis and twice the percentage lysis of the respective control (preceding column to the left) are considered as positive and shown in bold. binant rotavirus proteins VP1, VP4, VP6 and VP7 induced CD8 ÷ T lymphocytes that mediated clearance of chronic rotavirus infection in SCID mice. We decided to test whether the response induced by RF was also induced by this type of immunogen. Fig. 3 (c) shows that mice primed with Sf9 cells expressing the RF VP7 specifically recognized the same peptides as mice primed with the virus and P15. With both types of effector cells the response against P7 and P15 (seen only with the BacRF9-primed CTLs) was positive in only three of six experiments performed (see for example Fig. 4) . At an E:T ratio of 10, BacRF9-primed CTLs lysed RF-and VV7-infected cells (63.7 and 88.6% specific lysis respectively) but not control targets incubated with the supernatant of mock-infected MA104 cells or D4-infected cells (14 and 9.5% specific lysis respectively).
Effectors from mice inoculated with non-recombinant AcRP6-SC virus-infected Sf9 cells did not lyse any of the four target cells (less than 8 % specific lysis for the four target cells at the same E:T ratio).
P3 is immunodominant in the response against VV7
Of the peptides recognized in the previous experiments only P3 was able to sensitize cells for lysis at concentrations below 5 x 10 7 M (Fig. 4) . As it has been shown that higher peptide concentrations can result in the detection of non-physiological responses this experiment suggests that the only peptide corresponding to a CTL epitope is P3. The CTL response against a protein or against a virus is generally focused on one or two immunodominant epitopes (Braciale et al., 1989; Van Bleek & Nathenson, 1990) . In order to determine whether P3 was dominant in the bulk response against VV7, we used an unlabelled target inhibition assay (Braciale et al., 1989; Van Bleek & Nathenson, 1990) . This test evaluates the capacity of unlabelled targets to compete with labelled targets for recognition by effector cells. Only unlabelled targets that present the epitope recognized by the effectors should inhibit the lysis of labelled targets. As seen in Fig. 5 , only unlabelled targets treated with P3 can inhibit the response against VV7 by both RF-and BacRF9-primed CTLs.
P3 can stimulate in vitro CTLs primed by the RF virus and is Kb-restricted
To determine whether P3 was capable of restimulating in vitro RF-primed CTLs we used a protocol similar to that used by Shirai et al. (1992a) . We incubated the stimulator cells used for the in vitro stimulation with doses of 10, 1 and 0.1 gM of peptide before mixing them with the effector cells. Table 1 shows that effector cells restimulated with 10 gM of peptide were not able to lyse targets infected with RF and lyse only marginally those infected with VV7 whereas those restimulated with 0-1 gM were able to lyse both. An analogous negative dose effect has been reported previously (Shirai et al., 1992a) . (Fig. 6) confirming that the response against P3 is Kb-restricted.
The response against P3 is focused on the carboxyterminal motif present on the peptide
As for the screening experiments, P3 was synthesized containing two overlapping K b motifs, eight amino acid peptides corresponding to these motifs were synthesized and tested. The peptide titration experiment (Fig. 7) shows that P3-2, the peptide corresponding to the carboxy-terminal motif on P3 (IIYRFLLI) is recognized when diluted to concentrations similar to those of P3. The peptide P3-1 corresponding to the amino-terminal motif on P3 (DYIIYRFL) is recognized at a much lower level and only at high concentrations.
Discussion
We have identified the K~-restricted CTL epitope P3 (residues 31 to 40) of rotavirus VP7 that overlaps the H2 signal peptide (residues 33 to 48) (Charpilienne et al., 1986) . Effector cells primed by both RF and the baculovirus recombinant expressing VP7 are able to lyse target cells sensitized with this peptide at doses as low as 10 -l° M. It is immunodominant as judged by its capacity, bound to unlabelled targets, to inhibit the response of both these types of effector cells against VV7-infected cells. P3 is also able to restimulate in vitro, RF-primed effector cells, that specifically lyse target cells infected with VV7 and RF. P3 has two K b motifs and an extra valine at its carboxy terminus (Charpilienne et al., 1986) . Our results show that the response against P3 is focused on the carboxy-terminal motif and confirm the practical significance of the allele-specific motifs proposed by Falk et aI. (1991) for predicting class I-restricted T cell epitopes.
Two groups have reported recently that signal peptides (or fragments from them) are bound by HLA-A2 class I molecules in cells lacking the putative peptide transporter that introduces the peptides to be bound to the MHC class I molecules into the endoplasmic reticulum (Hunt et al., 1992; Wei & Creswell, 1992) . Buchmeier & Zinkernagel (1992) recently called attention to the fact that a lymphocytic choriomeningitis virus immunodominant peptide restricted by D b is a signal peptide. They proposed that CTL responses against peptides that are signal peptides may be biologically relevant. Our finding of another Kb-restricted immunodominant epitope overlapping a signal peptide reinforces this argument. To determine whether P3 is transported into the endoplasmic reticulum in a non-classical manner, it will be interesting to see whether T2 cells (lacking the described peptide transporters and transfected with K b) (Wei & Creswell, 1992) , are able to present P3 when infected with VV7.
The mechanism of induction of CTLs by the RF virus is yet to be established. In preliminary experiments we have detected infectious RF rotavirus in the lungs of mice up to 6 days after the immunization, but at present we do not have evidence that the virus is replicating in the mice. It is possible that our model resembles that of murine poliovirus (Kutubuddin et al., 1992) in which CTLs are induced by the virus which is non-replicative in mice. At present we favour the hypothesis that RF virus replicates to some extent in mice. It is encouraging for vaccine design to find the induction of the same immunodominant CTL epitope using two types of antigens (viral and recombinant). Our results are consistent with those of Hosmalin et al. (1992) who showed the induction of the same immunodominant CTL epitope using replicative and non-replicative antigens. Moreover they suggest that the same class I-restricted epitopes for a given protein and host are induced, irrespective of the context in which they are administered, as demonstrated for helper determinants (Brett et aL, 1991) .
The status of the other four peptides (P11, P6, P10 and P 16) that were consistently recognized in our experiments was not definitively established. It would not be surprising if they are minor CTL epitopes which we can detect owing to the small size of the peptides used for the screening experiments. There is a precedent for mice recognizing multiple CTL epitopes on one protein; at least five CTL epitopes in the large T antigen of simian virus 40 were recognized by C57BL/6 mice (Deckhut et aL, 1992) . Nonetheless it is generally accepted that physiologically active peptides are recognized in a CTL assay at concentrations below 5 x 10 7 M and that above this concentration cross-reactive or non-physiological responses are seen (Milligan et aL, 1990; Speiser et al., 1992) . Therefore responses to P6, P10, P11 and P16 may represent cross-reactive responses to P3.
The sequences of the dominant epitopes P3 and P3-2 are identical in the human WA and RF strains, but differ by three and two amino acids, respectively, from that of SA11 (Nishikawa et aL, 1989) . This fact could account for the relatively less intense response seen against VVTinfected cells after restimulating in vitro RF-primed effectors with SA11, as compared with WA-restimulated CTLs (Fig. 2) . That the SAll-restimulated CTLs recognize RF-infected cells better than do CTLs restimulated by WA could possibly be due to the presence of CTLs specific for another rotavirus protein in the SA11 cultures.
Recently, Ward et al. (1992) described protection experiments in the adult mouse in which no correlation was seen between protection and the induction of neutralizing antibodies. It will be interesting to determine whether cells specific for P3 are protective in a similar model. We are currently testing whether the CTLs induced with mouse rotavirus strains recognize P3.
